Focal adhesion kinase promotes ribosome biogenesis to drive advanced thyroid cancer cell growth and survival.
Saved in:
| Title: | Focal adhesion kinase promotes ribosome biogenesis to drive advanced thyroid cancer cell growth and survival. |
|---|---|
| Authors: | Kellett MD; Division of Endocrinology, Metabolism, and Diabetes, Department of Medicine, University of Colorado, Aurora, CO, United States., Sharma V; Division of Endocrinology, Metabolism, and Diabetes, Department of Medicine, University of Colorado, Aurora, CO, United States., Sherlock ME; Department of Biochemistry and Molecular Genetics, University of Colorado, Aurora, CO, United States., Pugazhenthi U; Division of Endocrinology, Metabolism, and Diabetes, Department of Medicine, University of Colorado, Aurora, CO, United States., Rose MM; Division of Endocrinology, Metabolism, and Diabetes, Department of Medicine, University of Colorado, Aurora, CO, United States., Joshi MU; Department of Pharmacology, University of Colorado, Aurora, CO, United States.; University of Colorado Cancer Center, University of Colorado, Aurora, CO, United States., Dzieciatkowska M; Division of Structural Biology and Biophysics, Department of Medicine, University of Colorado, Aurora, CO, United States., Nguyen V; Department of Pharmaceutical Sciences, Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado, Aurora, CO, United States., Reigan P; Department of Pharmaceutical Sciences, Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado, Aurora, CO, United States., Hansen KC; Division of Structural Biology and Biophysics, Department of Medicine, University of Colorado, Aurora, CO, United States., Kieft JS; Department of Biochemistry and Molecular Genetics, University of Colorado, Aurora, CO, United States., Schweppe RE; Division of Endocrinology, Metabolism, and Diabetes, Department of Medicine, University of Colorado, Aurora, CO, United States.; University of Colorado Cancer Center, University of Colorado, Aurora, CO, United States. |
| Source: | Frontiers in oncology [Front Oncol] 2025 May 19; Vol. 15, pp. 1252544. Date of Electronic Publication: 2025 May 19 (Print Publication: 2025). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2234-943X |
|---|---|
| DOI: | 10.3389/fonc.2025.1252544 |
